Acute Exacerbations of COPD in the United States: Inpatient Burden and Predictors of Costs and Mortality

References

• Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000 Feb; 117(2 Suppl):5S–9S.
   PubMed Web of Science ®Google Scholar
• Strassels SA, Smith DH, Sullivan SD, Mahajan PS. The costs of treating COPD in the United States. Chest 2001 Feb; 119(2):344–352.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health, National Heart, Lung, and Blood Institute. Morbidity and mortality: 2009 chart book on cardiovascular, lung, and blood diseases [Internet]. National Heart, Lung, and Blood Institute; 2009 October [cited 2011 Jun 30]. Available from: http://www.nhlbi.nih.gov/resources/docs/2009_ChartBook.pdf.
   Google Scholar
• Skrepnek GH, Skrepnek SV. Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. Am J Manag Care 2004 Jul;10(5 Suppl):S129–138.
   PubMed Web of Science ®Google Scholar
• Druss BG, Marcus SC, Olfson M, Pincus HA. The most expensive medical conditions in America. Health Aff (Millwood) 2002 Jul–Aug;21(4):105–111.
   PubMed Web of Science ®Google Scholar
• American Lung Association. Trends in COPD (chronic bronchitis and emphysema): morbidity and mortality [Internet]. American Lung Association, Research and Program Services, Epidemiology and Statistics Unit; 2010 Feb [cited 2011 Jun 30]. Available from: http://www.lungusa.org/finding-cures/our-research/trend-reports/copd-trend-report.pdf.
   Google Scholar
• Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J. Assessment of the economic burden of COPD in the U.S.: A review and synthesis of the literature. COPD 2006 Dec; 3(4):211–218.
   PubMedGoogle Scholar
• Rennard SI, Farmer SG. Exacerbations and progression of disease in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1(2):88–92.
   PubMedGoogle Scholar
• Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003 May 26; 163(10):1180–1186.
   PubMed Web of Science ®Google Scholar
• Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995 Dec 20; 274(23):1852–1857.
   PubMed Web of Science ®Google Scholar
• Connors AF, Jr, Dawson NV, Thomas C, Harrell FE,Jr, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA. Outcomes following acute exacerbation of severe chronic obstructive lung disease. the SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med 1996 Oct; 154(4 Pt 1):959–967.
   PubMed Web of Science ®Google Scholar
• Nevins ML, Epstein SK. Predictors of outcome for patients with COPD requiring invasive mechanical ventilation. Chest 2001 Jun; 119(6):1840–1849.
   PubMed Web of Science ®Google Scholar
• Halpern MT, Stanford RH, Borker R. The burden of COPD in the U.S.A.: Results from the confronting COPD survey. Respir Med 2003 Mar; 97 Suppl C:S81–89.
   PubMed Web of Science ®Google Scholar
• O'Brien JA, Ward AJ, Jones MK, McMillan C, Lordan N. Utilization of health care services by patients with chronic obstructive pulmonary disease. Respir Med 2003 Jan; 97 Suppl A:S53–58.
   PubMedGoogle Scholar
• Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004 Jun; 23(6):932–946.
   PubMed Web of Science ®Google Scholar
• HCUPnet: Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS) [Internet]. Rockville: Agency for Healthcare Research and Quality. 1997–2008 - [cited 2011 Jun 30]. Available from: http://hcupnet.ahrq.gov/HCUPnet.jsp?Id = 226284BF0BAE1506&Form = SelLAY&JS = Y&Action = %3E%3ENext%3E%3E&_LAY = Researcher.
   Google Scholar
• Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: A review. COPD 2010 Jun; 7(3):214–228.
   PubMedGoogle Scholar
• Halpern MT, Higashi MK, Bakst AW, Schmier JK. The economic impact of acute exacerbations of chronic bronchitis in the United States and Canada: A literature review. J Manag Care Pharm 2003 Jul-Aug; 9(4):353–359.
   PubMedGoogle Scholar
• Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. Treatment cost of acute exacerbations of chronic bronchitis. Clin Ther 1999 Mar; 21(3):576–591.
   PubMed Web of Science ®Google Scholar
• Saint S, Flaherty KR, Abrahamse P, Martinez FJ, Fendrick AM. Acute exacerbation of chronic bronchitis: Disease-specific issues that influence the cost-effectiveness of antimicrobial therapy. Clin Ther 2001 Mar; 23(3):499–512.
   PubMed Web of Science ®Google Scholar
• Stanford RH, Shen Y, McLaughlin T. Cost of chronic obstructive pulmonary disease in the emergency department and hospital: An analysis of administrative data from 218 US hospitals. Treat Respir Med 2006; 5(5):343–349.
   PubMedGoogle Scholar
• Bustamante-Fermosel A, De Miguel-Yanes JM, Duffort-Falco M, Munoz J. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: The burden of clinical features. Am J Emerg Med 2007 Jun;25(5):515–522.
   PubMed Web of Science ®Google Scholar
• Fuso L, Incalzi RA, Pistelli R, Muzzolon R, Valente S, Pagliari G, Gliozzi F, Ciappi G. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995 Mar;98(3):272–277.
   PubMed Web of Science ®Google Scholar
• Hutchinson A, Brand C, Irving L, Roberts C, Thompson P, Campbell D. Acute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: Contribution of disease severity, infection and chronic heart failure. Intern Med J 2010 May; 40(5):364–371.
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. Global Initiative for Chronic Obstructive Lung Disease; [updated 2005; cited 2011 June 30]. 3 p. Available from: http://www.goldcopd.org/uploads/users/files/GOLDReport2006_0122.pdf.
   Google Scholar
• Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Co-morbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008 May 1; 5(4):549–555.
   PubMedGoogle Scholar
• Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB. COPD as a lung disease with systemic consequences–clinical impact, mechanisms, and potential for early intervention. COPD 2008 Aug; 5(4):235–256.
   PubMedGoogle Scholar
• Bradley EH, Herrin J, Curry L, Cherlin EJ, Wang Y, Webster TR, Drye EE, Normand SL, Krumholz HM. Variation in hospital mortality rates for patients with acute myocardial infarction. Am J Cardiol 2010 Oct 15; 106(8):1108–1112.
   PubMed Web of Science ®Google Scholar
• Ghaferi AA, Osborne NH, Birkmeyer JD, Dimick JB. Hospital characteristics associated with failure to rescue from complications after pancreatectomy. J Am Coll Surg 2010 Sep; 211(3):325–330.
   PubMed Web of Science ®Google Scholar
• Healthcare Cost and Utilization Project (HCUP). Introduction to the HCUP nationwide inpatient sample (NIS) 2006 [Internet]. Rockville (MD): Agency for Healthcare Research and Quality; 2008 May 14 [cited 2011 Jun 30]. Available from: http://www.hcup-us.ahrq.gov/db/nation/nis/2006NIS_INTRODUCTION.pdf.
   Google Scholar
• Healthcare Cost and Utilization Project (HCUP). Cost-to-charge ratio files: 2006 nationwide inpatient sample (NIS) user guide [Internet]. Rockville (MD): Agency for Healthcare Research and Quality; 2008 Dec 1 [cited 2011 Jun 30]. Available from: http://www.hcup-us.ahrq.gov/db/state/CCR2006NISUserGuide.pdf.
   Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical co-morbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992 Jun; 45(6):613–619.
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of co-morbidities. Eur Respir J 2006 Dec; 28(6):1245.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal T, Jeffries DJ, Wedzicha JA. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J 1999 Apr; 13(4):844–849.
   PubMed Web of Science ®Google Scholar
• Gump DW, Phillips CA, Forsyth BR, McIntosh K, Lamborn KR, Stouch WH. Role of infection in chronic bronchitis. Am Rev Respir Dis 1976 Apr; 1 13(4):465–474.
   Google Scholar
• Holguin F, Folch E, Redd SC, Mannino DM. Co-morbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005 Oct; 128(4):2005–2011.
   PubMed Web of Science ®Google Scholar
• Almagro P, Calbo E, Ochoa de Echaguen A, Barreiro B, Quintana S, Heredia JL, Garau J. Mortality after hospitalization for COPD. Chest 2002 May; 121(5):1441–1448.
   PubMed Web of Science ®Google Scholar
• Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E, Jr, She D. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006 Jan; 16(1):63–70.
   PubMed Web of Science ®Google Scholar
• Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997 Dec; 10(12):2794–2800.
   PubMed Web of Science ®Google Scholar
• Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T, Lindberg E, Brondum E, Aine T, Bakke P, Janson C. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med 2007 Sep; 101(9):1954–1960.
   PubMed Web of Science ®Google Scholar
• Gulsvik A, Hansteen V, Sivertssen E. Cardiac arrhythmias in patients with serious pulmonary diseases. Scand J Respir Dis 1978 Jun; 59(3):154–159.
   PubMedGoogle Scholar
• Grasso ME, Weller WE, Shaffer TJ, Diette GB, Anderson GF. Capitation, managed care, and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 Jul; 158(1):133–138.
   PubMed Web of Science ®Google Scholar
• Lin PJ, Shaya FT, Scharf SM. Economic implications of co-morbid conditions among medicaid beneficiaries with COPD. Respir Med 2010 May; 104(5):697–704.
   PubMed Web of Science ®Google Scholar
• de Miguel Diez J, Carrasco Garrido P, Garcia Carballo M, Gil de Miguel A, Rejas Gutierrez J, Bellon Cano JM, Hernandez Barrera V, Jimenez Garcia R. Determinants and predictors of the cost of COPD in primary care: A spanish perspective. Int J Chron Obstruct Pulmon Dis 2008; 3(4):701–712.
   PubMedGoogle Scholar
• National Institutes of Health, National Heart, Lung, and Blood Institute. Morbidity and mortality: 2007 chart book on cardiovascular, lung, and blood diseases [Internet]. National Heart, Lung, and Blood Institute; 2007 June [cited 2011 Jun 30]. Available from: http://www.nhlbi.nih.gov/resources/docs/07-chtbk.pdf.
   Google Scholar
• Wilson L, Devine EB, So K. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. Respir Med 2000 Mar; 94(3):204–213.
   PubMed Web of Science ®Google Scholar
• Utah Health Data Committee. 1993 Hospital Financial and Utilization Profile Standard Report No.: ST-1 [Internet]. Utah Office of Health Data Analysis, Utah Department of Health.; c1995 [cited 2011 Jun 30]. Available from: http://health.utah.gov/hda/st1/body2.html.
   Google Scholar
• Simoens S, Decramer M, Laekeman G. Economic aspects of antimicrobial therapy of acute exacerbations of COPD. Respir Med. 2007 Jan; 101(1):15–26.
   PubMed Web of Science ®Google Scholar